MILAN–(BUSINESS WIRE)–Regulatory News: Kaleon S.p.A. (Paris:ALKLN) (MIL:KLN), a company listed on Euronext Growth Milan and Euronext Growth Paris, active in the management and enhancement of cultural, environmental and tourism assets, announces the signing of a five-year agreement with the Italian Tennis and Padel Federation (FITP) and the Nitto ATP Finals, one of the world’s most prestigious and widely followed international sporting events. The agreement marks an important milestone in Kale
Month: September 2026
MILAN–(BUSINESS WIRE)–Regulatory News: Kaleon S.p.A. (Paris:ALKLN) (MIL:KLN), société cotée sur Euronext Growth Milan et Euronext Growth Paris, active dans la gestion et la valorisation de patrimoines culturels, environnementaux et touristiques, annonce la signature d’un accord de cinq ans avec la Fédération italienne de tennis et de padel (FITP) et les Nitto ATP Finals, l’un des événements sportifs internationaux les plus prestigieux et les plus suivis au monde. Cet accord marque une étape i
NEW YORK–(BUSINESS WIRE)– #creditratingagency–KBRA assigns preliminary ratings to six classes of notes issued by First Investors Auto Owner Trust 2026-2 (“FIAOT 2026-2”), an asset-backed securitization collateralized by a pool of auto loans. FIAOT 2026-2 represents the second term ABS securitization in 2026 for Stellantis Financial Services, Inc. d/b/a First Investors Financial Services (“SFS” or the “Company”) and the sixth since the Company’s acquisition by Stellantis N.V. in 2021. FIAOT 2026-2 will issue six c
SHARJAH, United Arab Emirates–(BUSINESS WIRE)–Sharjah Advocates More Dominant Role for Women in Technology under 2050 Roadmap
GAINESVILLE, Fla.–(BUSINESS WIRE)–Orthopedic Care Partners (OCP), a leading orthopedic practice management platform, today announced the appointment of Alex Dashe as President of its Arizona Division, strengthening the organization’s leadership in Arizona as it continues to expand its physician partnerships and support the growth of its practices across the market. Dashe will join OCP this week and work closely with the outgoing Arizona Division President, Paula Hecht, through her planned tra
Press release
Paris, 24 September 2026
Transactions carried out as part of a share buyback program and outside of a liquidity contract
Orange announces that it has purchased treasury shares within the framework of its share buyback program.
These shares have been acquired to honor obligations related to long-term incentive plans for corporate officers and senior employees. The long-term incentive plans, which are conditional on presence and performance, were set up with the aim of involving key Group managers in the success of its strategic plan.
Name of the issuer: Orange (LEI: 969500MCOONR8990S771)
References of the share buyback program: A description of the program authorized by the Shareholders’ General Meeting held on 19 May 2026 (13th resolution) can be found in Orange’s 2025 universal registration document (section 6.5)
Securities identifying code: Ordinary shares (ISIN: 0000133308), listed on Euronext Paris / Compartment A
Start date of the program: The 13th resolution of the shareholders’ general meeting held on 19 May 2026 was activated at the Board of Directors meeting on 19 May 2026.
Cash purchases of shares between 16 and 22 September 2026:
| Trading date | Type of transaction | Number of shares | Daily weighted average purchase price (€) | Amount (€) |
| 16 September 2026 | Purchase | 287,206 | 15.8754€ | 4,559,510.13€ |
| 17 September 2026 | Purchase | 996,784 | 15.9821€ | 15,930,701.57€ |
| 18 September 2026 | Purchase | 1,222,336 | 15.1639€ | 18,535,380.87€ |
| 21 September 2026 | Purchase | 1,264,317 | 15.0267€ | 18,998,512.26€ |
| 22 September 2026 | Purchase | 729,357 | 14.6971€ | 10,719,432.76€ |
| Total | Purchase | 4,500,000 | 15.2763€ | 68,743,537.60€ |
None of these shares were purchased as part of a share liquidity contract. Detailed information on these transactions may be found on the Orange website (Orange Investors’ Library).
About Orange
Orange is one of the world’s leading telecommunications operators. The Group aims to be the trusted partner for everyday digital life by providing individuals, businesses and communities with reliable connectivity and innovative services. As of the end of 2025, Orange connects 340 million customers (including MasOrange) across 26 countries and generated 40.4 billion euros in revenues.
As a trusted player, Orange leverages the excellence of its very high-speed broadband networks to deploy digital infrastructure in Europe, Africa and the Middle East. The Group is a European leader in fiber, with 100 million connectable households, and convergent offers. In France, Orange connects 34 million customers and was ranked No. 1 by the regulator Arcep for the quality of its mobile network for the 15th consecutive year. In Africa and the Middle East, the Group’s growth engine, Orange serves nearly 180 million customers and promotes digital and financial inclusion through its connected solutions.
Under the Orange Business brand, the Group supports companies in transforming their networks as well as in AI, trusted cloud and cybersecurity. Orange is also a major player in the wholesale market, where it has a leading global telecom infrastructure and significant capabilities for deploying and operating submarine cables. A committed innovator, Orange relies on 700 researchers and holds a portfolio of 11,000 patents.
Orange is listed on Euronext Paris (symbol ORA). More information: www.orange.com.
Orange and any other Orange product or service names mentioned in this material are trademarks of Orange or Orange Brand Services Limited.
Press contact:
Tom Wright; tom.wright@orange.com
Attachment
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones for facial recognition to body cameras.
NORTH PALM BEACH, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) — SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced an update to shareholders on the liquidation of portfolio holdings Vistagen Therapeutics (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company, and Greenland Mines (Nasdaq: GRML), a critical and precious minerals development company.
Additionally, the Company has added an investment in Onconetix Inc. (Nasdaq: ONCO). Onconetix has previously announced an agreement to acquire Realbotix LLC.
Realbotix utilizes a proprietary, patented robotic eyeball technology and an AI vision system known as Vinci. Developed by Realbotix, this hardware and software integration embeds cameras and tracking lenses directly inside the robot’s eyeballs, rather than hiding them in the forehead or chest like standard humanoids. The Vinci AI Vision System enables the hardware lenses to detect motion, recognize returning users, and identify objects or colors in the surrounding environment. The in-eye sensors analyze human micro-expressions to gauge emotional states (such as confusion, engagement, or frustration) and automatically adapt the robot’s conversation via integrated large language models (LLMs).
About SRX Global Inc.
SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements, including statements regarding the Company’s investment strategy, capital allocation and portfolio positioning, the redeployment of proceeds from the positions described above, the anticipated benefits of the Company’s investment in Onconetix, and the completion, timing and potential benefits of Onconetix’s pending acquisition of Realbotix LLC. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRX Global Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
srx@kcsa.com
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced newly published data in JAMA Network Open showing that Breast Cancer Index® (BCI®) test results led physicians to change their extended endocrine therapy recommendations for 42% of patients. In two-thirds of those cases, physicians changed their recommendation against extending treatment.1 The findings come from a large-scale BCI Registry Study conducted across multiple institutions at
Frøya, Norway, 24 September 2026:
Notice is given to the shareholders of Kaldvík AS (the “Company“) that an extraordinary general meeting will be held on 8 October 2026 at 12:00 hours CEST.
On 22 September 2026, the board of directors received a request from Austur Holding AS, reg. no. 930 310 387 (“Austur”), holding approximately 60.02% of the shares in the Company, to convene an extraordinary general meeting of the Company to resolve on changes to the composition of the board of directors of the Company.
The request states that Austur will propose that current board member Martin Lein Staveli be replaced by Stig Wærnes, to be elected for a period until the Company’s annual general meeting in 2028.
Stig Wærnes brings extensive board-level, executive and advisory experience, including from several publicly listed companies. His experience includes board and audit committee roles at BEWI ASA, executive and board-related roles at KMC Properties ASA and BEVEST ASA, and an executive role at Logistea AB, listed on Nasdaq Stockholm. He has also held a number of other board and executive positions and has broad experience as an auditor and adviser to companies within the industrial and seafood sectors.
Stig Wærnes is also a board member of Heimstø AS, a shareholder of Austur.
Stig Wærnes has no direct or indirect ownership interest in either the Company or Austur.
The extraordinary general meeting will be held digitally through Lumi AGM. It will not be possible to attend in person. Shareholders are encouraged to pre-register their attendance to the meeting and shareholders may also provide a proxy. Deadline for the pre-registration and registration of proxies is 6 October 2026 at 12:00 hours (CEST).
The notice of the extraordinary general meeting, including the attendance and proxy forms, is attached to this announcement.
The notice of the extraordinary general meeting will be sent electronic or by post to all shareholders with known address.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
For further information, please contact:
Vidar Aspehaug, CEO: +47 913 05 017 (mobile)
About Kaldvík AS
Kaldvík AS is the leading salmon farmer in Iceland. Kaldvik AS has a well-developed and fully integrated value-chain, enabling the group to provide its customers with a sustainable premium product. Kaldvik AS is dual listed on Euronext Growth Oslo and First North Iceland Growth Market. See https://www.kaldvik.is for more information about the Company.
Attachment
アラブ首長国連邦・アブダビ–(BUSINESS WIRE)–（ビジネスワイヤ） — 行動・代謝・環境に関する健康リスクに対処した場合、2050年には世界の年間GDPを推定16.4兆米ドル押し上げる可能性があります。これらの分析結果は、「健康的な生活の未来：16.4兆米ドルの機会（The Future of Healthy Living: A $16.4 Trillion Opportunity）」という、Future Health – A Global Initiative by Abu Dhabi、McKinsey Health Institute（MHI）、アブダビ保健局（Department of Health – Abu Dhabi）のHealthy Living部門が共同執筆し、ニューヨークでの第81回国連総会（UNGA 81）の開催に合わせて発表した新たなホワイトペーパーに示されています。 各国政府が、2025年12月に採択された非感染性疾患およびメンタルヘルスに関する国連政治宣言を国内での行動へと移そうとする中、このホワイトペーパーは公表されました。健康的な生活が